FDA Determines Regulatory Review Period for PAYLEAN Patent Extension

Summary

The Food and Drug Administration (FDA) has officially confirmed the regulatory review period for PAYLEAN, a patent extension application submitted to the Department of Commerce, and is publishing this notice as required by law.